Location of Repository

Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial)

By Osman Tiryakioğlu, Gürdeniz Yıldız, Hakan Vural, Tugrul Goncu, Ahmet Ozyazıcıoglu and Şenol Yavuz
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2483980
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2000). Bepperling F: A novel HES for effective perioperative plasma volume substitution in cardiac surgery.
    2. Edmunds LH Jr: Extracorporeal Circulation: Perfusion Systems.
    3. (2003). HES and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Intern
    4. (2001). Isgro F: Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth
    5. Kirklin/Barratt-Boyes: Cardiac Surgery 3rd edition.
    6. (2003). Large-dose HES130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with HES 200/0.5 at recommended doses. Anesth
    7. (2004). Mohamed S: Selection of optimal quantity of hydroxyethyl starch in the cardiopulmonary bypass prime. Perfusion
    8. (1992). Pharmacology of dextrans. In Plasma volume expansion Edited by: Baron J.
    9. (2003). VVerling C: Influence of two different volume replacement regiments on renal function in patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin. Intensive Care Med
    10. (2003). VVinkelmayer WC: Hetastarch and bleeding complications after coronary artery surgery.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.